Pancreatic Cancer
Conditions
Brief summary
To test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy.
Sponsors
Stanford University
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
- Adult patients (\>18) with histologically confirmed adenocarcinomas of the pancreas with a - treatment plan consisting of definitive or palliative radiation therapy and/or chemotherapy with or without surgery. * Negative urine pregnancy test if a woman of child-bearing potential (WOCBP). * WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study period. * All patients will be evaluated in a uniform manner at the Stanford GI Combined Modality Tumor Board to determine eligibility.
Exclusion criteria
1. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. 2\. Any concurrent malignancy other than non-melanomaskin cancer, or carcinomainsitu of the cervix. Patients with a previous malignancy without evidence of disease for \>5 years will be allowed to enter the trial. 3\. WOCBP who is pregnant or breastfeeding. 4. Inability to sign written consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the performance of the novel imaging methods | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlate FLT activity with clinical outcomes | — |
Countries
United States
Outcome results
None listed